Black Diamond Therapeutics
BDTX
BDTX
50 hedge funds and large institutions have $40.6M invested in Black Diamond Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-9
Holders Change %
-15.25%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
17
Closed
9
Calls
$45K
Puts
$1K
Net Calls
+$44K
Net Calls Change
+$71K
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
-$449K |
2 |
Citadel Advisors
Miami,
Florida
|
-$408K |
3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$278K |
4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$268K |
5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$176K |